Katharine E. Stott

Prescott Street
Liverpool, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Liposomal antimicrobials in the fight against bacterial and fungal pathogens: Clinical successes and development challenges.

Liposomal antimicrobials in the fight against bacterial and fungal pathogens: Clinical successes and development challenges.

Journal: International journal of pharmaceutics: X

Published: October 10, 2025

Evaluating the Use of Lower Dose Flucytosine for the Treatment of Cryptococcal Meningitis: A Clinical Trial.

Evaluating the Use of Lower Dose Flucytosine for the Treatment of Cryptococcal Meningitis: A Clinical Trial.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: June 15, 2025

Relative Contribution of Pharmacokinetics and Immune Signatures to Clinical Outcomes in Patients With HIV-associated Cryptococcal Meningitis.

Relative Contribution of Pharmacokinetics and Immune Signatures to Clinical Outcomes in Patients With HIV-associated Cryptococcal Meningitis.

Journal: Open forum infectious diseases

Published: February 25, 2025

Integration of genomic and pharmacokinetic data to predict clinical outcomes in HIV-associated cryptococcal meningitis.

Integration of genomic and pharmacokinetic data to predict clinical outcomes in HIV-associated cryptococcal meningitis.

Journal: mBio

Published: August 27, 2024

Challenges for global antibiotic regimen planning and establishing antimicrobial resistance targets: implications for the WHO Essential Medicines List and AWaRe antibiotic book dosing.

Challenges for global antibiotic regimen planning and establishing antimicrobial resistance targets: implications for the WHO Essential Medicines List and AWaRe antibiotic book dosing.

Journal: Clinical microbiology reviews

Published: March 04, 2024

Pharmacodynamics of ATI-2307 in a rabbit model of cryptococcal meningoencephalitis.

Pharmacodynamics of ATI-2307 in a rabbit model of cryptococcal meningoencephalitis.

Journal: Antimicrobial agents and chemotherapy

Published: September 20, 2023

Population pharmacokinetics and CSF penetration of flucytosine in adults with HIV-associated cryptococcal meningoencephalitis.

Population pharmacokinetics and CSF penetration of flucytosine in adults with HIV-associated cryptococcal meningoencephalitis.

Journal: The Journal of antimicrobial chemotherapy

Published: November 25, 2022

Population pharmacokinetics of liposomal amphotericin B in adults with HIV-associated cryptococcal meningoencephalitis.

Population pharmacokinetics of liposomal amphotericin B in adults with HIV-associated cryptococcal meningoencephalitis.

Journal: The Journal of antimicrobial chemotherapy

Published: August 22, 2022

Population Pharmacokinetics and Pharmacodynamics of Itraconazole for Disseminated Infection Caused by Talaromyces marneffei.

Population Pharmacokinetics and Pharmacodynamics of Itraconazole for Disseminated Infection Caused by Talaromyces marneffei.

Journal: Antimicrobial agents and chemotherapy

Published: August 09, 2021

Sensitivity of SARS-CoV-2 RNA polymerase chain reaction using a clinical and radiological reference standard.

Sensitivity of SARS-CoV-2 RNA polymerase chain reaction using a clinical and radiological reference standard.

Journal: The Journal of infection

Published: January 11, 2021

Cryptococcal meningoencephalitis: time for action.

Cryptococcal meningoencephalitis: time for action.

Journal: The Lancet. Infectious diseases

Published: July 21, 2020

Evidence for Expanding the Role of Streptomycin in the Management of Drug-Resistant Mycobacterium tuberculosis.

Evidence for Expanding the Role of Streptomycin in the Management of Drug-Resistant Mycobacterium tuberculosis.

Journal: Antimicrobial agents and chemotherapy

Published: May 05, 2020

Showing 1-12 of 28

Last Updated: 09/26/2026